AMRN: amarincorp.com Expected earnings per share growth for next year

Amarin Corporation plc (AMRN) attracts leading cardiologists through a bonus system. The current trajectory of next year's EPS forecasts on the GURU.Markets chart confirms this trend, where the value 43.70 reflects the metric's balance. Supply stability is ensured by a network of European plants, although the loss of patents is forcing the company to aggressively cut costs and abandon M&A deals.
Amarin Corporation - analytical breakdowns and key metrics (AMRN)

Amarin Corporation plc (AMRN) operates in the capital-intensive cardiovascular therapy sector characterized by strict patent control. This indicator measures aggregated analyst expectations for earnings changes, reacting in real-time to regulatory risks and the cost of clinical trials. The metric captures the flow of institutional capital between assets prior to the publication of official financial statements. By analyzing the projected trend of net income, an investor can promptly detect a business overvaluation.